{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T16:58:49Z","timestamp":1794848329814,"version":"4.9.1"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T00:00:00Z","timestamp":1762819200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["R01AG081421"],"award-info":[{"award-number":["R01AG081421"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000057","name":"U.S. Department of Health & Human Services | NIH | National Institute of General Medical Sciences","doi-asserted-by":"publisher","award":["P20 GM148326"],"award-info":[{"award-number":["P20 GM148326"]}],"id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000957","name":"Alzheimer's Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000957","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Neurosci"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1038\/s41593-025-02094-y","type":"journal-article","created":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T10:02:15Z","timestamp":1762855335000},"page":"2461-2475","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["APOE4 to APOE2 allelic switching in mice improves Alzheimer\u2019s disease-related metabolic signatures, neuropathology and cognition"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8922-8850","authenticated-orcid":false,"given":"Lesley R.","family":"Golden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dahlia S.","family":"Siano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isaiah O.","family":"Stephens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"MacLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgia L.","family":"Nolt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1971-6028","authenticated-orcid":false,"given":"Jessica L.","family":"Funnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhil V.","family":"Pallerla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangderk","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathryn","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haining","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clairity","family":"Voy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Callie M.","family":"Whitus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brandon C.","family":"Farmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5697-5817","authenticated-orcid":false,"given":"Dale O.","family":"Cowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon L.","family":"Macauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M.","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4183-0049","authenticated-orcid":false,"given":"Josh M.","family":"Morganti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0134-7586","authenticated-orcid":false,"given":"Lance A.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,11]]},"reference":[{"key":"2094_CR1","doi-asserted-by":"publisher","first-page":"1284","DOI":"10.1001\/jamaneurol.2023.3599","volume":"80","author":"ME Belloy","year":"2023","unstructured":"Belloy, M. E. et al. APOE genotype and Alzheimer disease risk across age, sex, and population ancestry. JAMA Neurol. 80, 1284\u20131294 (2023).","journal-title":"JAMA Neurol."},{"key":"2094_CR2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1038\/ng0694-180","volume":"7","author":"E Corder","year":"1994","unstructured":"Corder, E. et al. Protective effect of apolipoproteinE type 2 allele for late onset Alzheimer disease. Nat. Genet. 7, 180\u2013184 (1994).","journal-title":"Nat. Genet."},{"key":"2094_CR3","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.exger.2014.02.004","volume":"53","author":"N Garatachea","year":"2014","unstructured":"Garatachea, N. et al. ApoE gene and exceptional longevity: insights from three independent cohorts. Exp. Gerontol. 53, 16\u201323 (2014).","journal-title":"Exp. Gerontol."},{"key":"2094_CR4","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1136\/jnnp.73.6.672","volume":"73","author":"R Wilson","year":"2002","unstructured":"Wilson, R., Bienias, J., Berry-Kravis, E., Evans, D. & Bennett, D. The apolipoprotein E \u03b52 allele and decline in episodic memory. J. Neurol. Neurosurg. Psychiatry 73, 672\u2013677 (2002).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"2094_CR5","doi-asserted-by":"publisher","first-page":"1304","DOI":"10.1016\/j.neuron.2022.03.004","volume":"110","author":"YA Martens","year":"2022","unstructured":"Martens, Y. A. et al. ApoE cascade hypothesis in the pathogenesis of Alzheimer\u2019s disease and related dementias. Neuron 110, 1304\u20131317 (2022).","journal-title":"Neuron"},{"key":"2094_CR6","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1186\/s13024-022-00574-4","volume":"17","author":"A-C Raulin","year":"2022","unstructured":"Raulin, A.-C. et al. ApoE in Alzheimer\u2019s disease: pathophysiology and therapeutic strategies. Mol. Neurodegener. 17, 72 (2022).","journal-title":"Mol. Neurodegener."},{"key":"2094_CR7","doi-asserted-by":"publisher","first-page":"5715","DOI":"10.1038\/s41380-021-01076-3","volume":"26","author":"N Brookhouser","year":"2021","unstructured":"Brookhouser, N., Raman, S., Frisch, C., Srinivasan, G. & Brafman, D. A. APOE2 mitigates disease-related phenotypes in an isogenic hiPSC-based model of Alzheimer\u2019s disease. Mol. Psychiatry 26, 5715\u20135732 (2021).","journal-title":"Mol. Psychiatry"},{"key":"2094_CR8","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1016\/j.neuron.2018.05.008","volume":"98","author":"YT Lin","year":"2018","unstructured":"Lin, Y. T. et al. APOE4 causes widespread molecular and cellular alterations associated with Alzheimer\u2019s disease phenotypes in human iPSC-derived brain cell types. Neuron 98, 1141\u20131154 (2018).","journal-title":"Neuron"},{"key":"2094_CR9","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1073\/pnas.0409072102","volume":"102","author":"J-C Dodart","year":"2005","unstructured":"Dodart, J.-C. et al. Gene delivery of human apolipoprotein E alters brain A\u03b2 burden in a mouse model of Alzheimer\u2019s disease. Proc. Natl Acad. Sci. USA 102, 1211\u20131216 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2094_CR10","doi-asserted-by":"publisher","first-page":"212ra161","DOI":"10.1126\/scitranslmed.3007000","volume":"5","author":"E Hudry","year":"2013","unstructured":"Hudry, E. et al. Gene transfer of human Apoe isoforms results in differential modulation of amyloid deposition and neurotoxicity in mouse brain. Sci. Transl. Med. 5, 212ra161 (2013).","journal-title":"Sci. Transl. Med."},{"key":"2094_CR11","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.neurobiolaging.2016.04.020","volume":"44","author":"L Zhao","year":"2016","unstructured":"Zhao, L. et al. Intracerebral adeno-associated virus gene delivery of apolipoprotein E2 markedly reduces brain amyloid pathology in Alzheimer\u2019s disease mouse models. Neurobiol. Aging 44, 159\u2013172 (2016).","journal-title":"Neurobiol. Aging"},{"key":"2094_CR12","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1016\/j.ymthe.2024.03.024","volume":"32","author":"RJ Jackson","year":"2024","unstructured":"Jackson, R. J. APOE2 gene therapy reduces amyloid deposition and improves markers of neuroinflammation and neurodegeneration in a mouse model of Alzheimer disease. Mol. Ther. 32, 1373\u20131386 (2024).","journal-title":"Mol. Ther."},{"key":"2094_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1089\/humc.2017.231","volume":"29","author":"J Rosenburg","year":"2018","unstructured":"Rosenburg, J. et al. AAVrh.10-mediated APOE2 central nervous system gene therapy for APOE4-associated Alzheimer\u2019s disease. Hum. Gene Ther. Clin. Dev. 29, 24\u201347 (2018).","journal-title":"Hum. Gene Ther. Clin. Dev."},{"key":"2094_CR14","unstructured":"Gene therapy for APOE4 homozygote of Alzheimer's disease https:\/\/clinicaltrials.gov\/study\/NCT03634007 (ClinicalTrials.gov, 2024)."},{"key":"2094_CR15","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1016\/j.neuron.2021.03.024","volume":"109","author":"C Wang","year":"2021","unstructured":"Wang, C. et al. Selective removal of astrocytic APOE4 strongly protects against tau-mediated neurodegeneration and decreases synaptic phagocytosis by microglia. Neuron 109, 1657\u20131674 (2021).","journal-title":"Neuron"},{"key":"2094_CR16","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1016\/j.neuron.2017.11.014","volume":"96","author":"TV Huynh","year":"2017","unstructured":"Huynh, T. V. et al. Age-dependent effects of apoE reduction using antisense oligonucleotides in a model of \u03b2-amyloidosis. Neuron 96, 1013\u20131023 (2017).","journal-title":"Neuron"},{"key":"2094_CR17","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1172\/JCI96429","volume":"128","author":"F Liao","year":"2018","unstructured":"Liao, F. et al. Targeting of nonlipidated, aggregated apoE with antibodies inhibits amyloid accumulation. J. Clin. Invest. 128, 2144\u20132155 (2018).","journal-title":"J. Clin. Invest."},{"key":"2094_CR18","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.neuron.2021.05.034","volume":"109","author":"Y Shi","year":"2021","unstructured":"Shi, Y. et al. Overexpressing low-density lipoprotein receptor reduces tau-associated neurodegeneration in relation to apoE-linked mechanisms. Neuron 109, 2413\u20132426 (2021).","journal-title":"Neuron"},{"key":"2094_CR19","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1001\/jamaneurol.2023.4983","volume":"81","author":"SE Salomonsson","year":"2024","unstructured":"Salomonsson, S. E. & Clelland, C. D. Building CRISPR gene therapies for the central nervous system: a review. JAMA Neurol. 81, 283\u2013290 (2024).","journal-title":"JAMA Neurol."},{"key":"2094_CR20","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1172\/JCI2673","volume":"102","author":"P Sullivan","year":"1998","unstructured":"Sullivan, P., Mezdour, H., Quarfordt, S. & Maeda, N. Type III hyperlipoproteinemia and spontaneous atherosclerosis in mice resulting from gene replacement of mouse Apoe with human Apoe*2. J. Clin. Invest. 102, 130\u2013135 (1998).","journal-title":"J. Clin. Invest."},{"key":"2094_CR21","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","volume":"124","author":"PM Sullivan","year":"2004","unstructured":"Sullivan, P. M., Mace, B. E., Maeda, N. & Schmechel, D. E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 124, 725\u2013733 (2004).","journal-title":"Neuroscience"},{"key":"2094_CR22","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1186\/s13195-019-0558-0","volume":"11","author":"I Lefterov","year":"2019","unstructured":"Lefterov, I. et al. APOE2 orchestrated differences in transcriptomic and lipidomic profiles of postmortem AD brain. Alzheimers Res. Ther. 11, 113 (2019).","journal-title":"Alzheimers Res. Ther."},{"key":"2094_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23762-0","volume":"12","author":"NF Fitz","year":"2021","unstructured":"Fitz, N. F. et al. Phospholipids of APOE lipoproteins activate microglia in an isoform-specific manner in preclinical models of Alzheimer\u2019s disease. Nat. Commun. 12, 3416 (2021).","journal-title":"Nat. Commun."},{"key":"2094_CR24","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41593-022-01222-2","volume":"26","author":"MH Murdock","year":"2023","unstructured":"Murdock, M. H. & Tsai, L.-H. Insights into Alzheimer\u2019s disease from single-cell genomic approaches. Nat. Neurosci. 26, 181\u2013195 (2023).","journal-title":"Nat. Neurosci."},{"key":"2094_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/alz.060565","volume":"19","author":"MA De Bastiani","year":"2023","unstructured":"De Bastiani, M. A. et al. Cross-species evidence of differential expression of S100A6 and SLC11A1 in the hippocampus of Alzheimer\u2019s disease patients and mouse models. Alzheimers Dement. 19, e060565 (2023).","journal-title":"Alzheimers Dement."},{"key":"2094_CR26","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao, N. et al. Alzheimer\u2019s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 106, 727\u2013742 (2020).","journal-title":"Neuron"},{"key":"2094_CR27","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41593-020-0624-8","volume":"23","author":"N Habib","year":"2020","unstructured":"Habib, N. et al. Disease-associated astrocytes in Alzheimer's disease and aging. Nat. Neurosci. 23, 701\u2013706 (2020).","journal-title":"Nat. Neurosci."},{"key":"2094_CR28","doi-asserted-by":"publisher","first-page":"1276","DOI":"10.1016\/j.cell.2017.05.018","volume":"169","author":"H Keren-Shaul","year":"2017","unstructured":"Keren-Shaul, H. et al. A unique microglia type associated with restricting development of Alzheimer\u2019s disease. Cell 169, 1276\u20131290 (2017).","journal-title":"Cell"},{"key":"2094_CR29","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1523\/JNEUROSCI.5476-05.2006","volume":"26","author":"Q Xu","year":"2006","unstructured":"Xu, Q. et al. Profile and regulation of apolipoprotein E (ApoE) expression in the CNS in mice with targeting of green fluorescent protein gene to the ApoE locus. J. Neurosci. 26, 4985\u20134994 (2006).","journal-title":"J. Neurosci."},{"key":"2094_CR30","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1016\/j.neuron.2016.11.030","volume":"92","author":"R Srinivasan","year":"2016","unstructured":"Srinivasan, R. et al. New transgenic mouse lines for selectively targeting astrocytes and studying calcium signals in astrocyte processes in situ and in vivo. Neuron 92, 1181\u20131195 (2016).","journal-title":"Neuron"},{"key":"2094_CR31","doi-asserted-by":"publisher","first-page":"89ra57","DOI":"10.1126\/scitranslmed.3002156","volume":"3","author":"JM Castellano","year":"2011","unstructured":"Castellano, J. M. et al. Human apoE isoforms differentially regulate brain amyloid-\u03b2 peptide clearance. Sci. Transl. Med. 3, 89ra57 (2011).","journal-title":"Sci. Transl. Med."},{"key":"2094_CR32","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306 (2019).","journal-title":"Cell Rep."},{"key":"2094_CR33","doi-asserted-by":"publisher","first-page":"112196","DOI":"10.1016\/j.celrep.2023.112196","volume":"42","author":"S Lee","year":"2023","unstructured":"Lee, S. et al. APOE modulates microglial immunometabolism in response to age, amyloid pathology, and inflammatory challenge. Cell Rep. 42, 112196 (2023).","journal-title":"Cell Rep."},{"key":"2094_CR34","doi-asserted-by":"publisher","first-page":"537","DOI":"10.3233\/JAD-2011-111202","volume":"29","author":"V Filippov","year":"2012","unstructured":"Filippov, V. et al. Increased ceramide in brains with Alzheimer\u2019s and other neurodegenerative diseases. J. Alzheimers Dis. 29, 537\u2013547 (2012).","journal-title":"J. Alzheimers Dis."},{"key":"2094_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0021-9258(19)40184-1","volume":"265","author":"JH Exton","year":"1990","unstructured":"Exton, J. H. Signaling through phosphatidylcholine breakdown. J. Biol. Chem. 265, 1\u20134 (1990).","journal-title":"J. Biol. Chem."},{"key":"2094_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-022-00516-0","volume":"17","author":"TE Mahan","year":"2022","unstructured":"Mahan, T. E. et al. Selective reduction of astrocyte apoE3 and apoE4 strongly reduces A\u03b2 accumulation and plaque-related pathology in a mouse model of amyloidosis. Mol. Neurodegener. 17, 13 (2022).","journal-title":"Mol. Neurodegener."},{"key":"2094_CR37","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1016\/j.cell.2022.05.017","volume":"185","author":"J Tcw","year":"2022","unstructured":"Tcw, J. et al. Cholesterol and matrisome pathways dysregulated in astrocytes and microglia. Cell 185, 2213\u20132233 (2022).","journal-title":"Cell"},{"key":"2094_CR38","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1038\/s41591-020-0879-3","volume":"26","author":"BN Ostendorf","year":"2020","unstructured":"Ostendorf, B. N. et al. Common germline variants of the human APOE gene modulate melanoma progression and survival. Nat. Med. 26, 1048\u20131053 (2020).","journal-title":"Nat. Med."},{"key":"2094_CR39","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1093\/aje\/kwr329","volume":"175","author":"MKM Adams","year":"2012","unstructured":"Adams, M. K. M. et al. Apolipoprotein E gene associations in age-related macular degeneration: the Melbourne Collaborative Cohort Study. Am. J. Epidemiol. 175, 511\u2013518 (2012).","journal-title":"Am. J. Epidemiol."},{"key":"2094_CR40","doi-asserted-by":"publisher","first-page":"2443","DOI":"10.1038\/npp.2015.95","volume":"40","author":"LA Johnson","year":"2015","unstructured":"Johnson, L. A. et al. ApoE2 exaggerates PTSD-related behavioral, cognitive, and neuroendocrine alterations. Neuropsychopharmacology 40, 2443\u20132453 (2015).","journal-title":"Neuropsychopharmacology"},{"key":"2094_CR41","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13024-024-00747-3","volume":"19","author":"H Wang","year":"2024","unstructured":"Wang, H. Whole-genome sequencing analysis reveals new susceptibility loci and structural variants associated with progressive supranuclear palsy. Mol. Neurodegener. 19, 61 (2024).","journal-title":"Mol. Neurodegener."},{"key":"2094_CR42","doi-asserted-by":"publisher","first-page":"150","DOI":"10.1016\/j.nbd.2013.12.016","volume":"64","author":"LA Johnson","year":"2014","unstructured":"Johnson, L. A. et al. Apolipoprotein E-low density lipoprotein receptor interaction affects spatial memory retention and brain ApoE levels in an isoform-dependent manner. Neurobiol. Dis. 64, 150\u2013162 (2014).","journal-title":"Neurobiol. Dis."},{"key":"2094_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.cell.2024.10.027","volume":"188","author":"JL Guo","year":"2025","unstructured":"Guo, J. L. et al. Decreased lipidated ApoE-receptor interactions confer protection against pathogenicity of ApoE and its lipid cargoes in lysosomes. Cell 188, 187\u2013206 (2025).","journal-title":"Cell"},{"key":"2094_CR44","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/s43587-023-00368-3","volume":"3","author":"N Koutsodendris","year":"2023","unstructured":"Koutsodendris, N. et al. Neuronal APOE4 removal protects against tau-mediated gliosis, neurodegeneration and myelin deficits. Nat. Aging 3, 275\u2013296 (2023).","journal-title":"Nat. Aging"},{"key":"2094_CR45","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1038\/s41593-024-01757-6","volume":"27","author":"A Anfray","year":"2024","unstructured":"Anfray, A. et al. A cell-autonomous role for border-associated macrophages in ApoE4 neurovascular dysfunction and susceptibility to white matter injury. Nat. Neurosci. 27, 2138\u20132151 (2024).","journal-title":"Nat. Neurosci."},{"key":"2094_CR46","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.neuron.2017.11.013","volume":"96","author":"C-C Liu","year":"2017","unstructured":"Liu, C.-C.et al. ApoE4 accelerates early seeding of amyloid pathology. Neuron 96, 1024\u20131032 (2017).","journal-title":"Neuron"},{"key":"2094_CR47","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1212\/WNL.0000000000002175","volume":"85","author":"PA Boyle","year":"2015","unstructured":"Boyle, P. A. et al. Cerebral amyloid angiopathy and cognitive outcomes in community-based older persons. Neurology 85, 1930\u20131936 (2015).","journal-title":"Neurology"},{"key":"2094_CR48","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1097\/NEN.0b013e31829a25b9","volume":"72","author":"PT Nelson","year":"2013","unstructured":"Nelson, P. T. et al. APOE-\u03b52 and APOE-\u03b54 correlate with increased amyloid accumulation in cerebral vasculature. J. Neuropathol. Exp. Neurol. 72, 708\u2013715 (2013).","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"2094_CR49","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1111\/bpa.12005","volume":"23","author":"M Zabel","year":"2013","unstructured":"Zabel, M. et al. A shift in microglial \u03b2-amyloid binding in Alzheimer\u2019s disease is associated with cerebral amyloid angiopathy. Brain Pathol. 23, 390\u2013401 (2013).","journal-title":"Brain Pathol."},{"key":"2094_CR50","doi-asserted-by":"publisher","first-page":"4999","DOI":"10.1002\/alz.13826","volume":"20","author":"D Munsterman","year":"2024","unstructured":"Munsterman, D. et al. Cerebral amyloid angiopathy and the immune system. Alzheimers Dement. 20, 4999\u20135008 (2024).","journal-title":"Alzheimers Dement."},{"key":"2094_CR51","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1016\/j.ajpath.2021.11.013","volume":"192","author":"J Gal","year":"2022","unstructured":"Gal, J. et al. Apolipoprotein E proteinopathy is a major dementia-associated pathologic biomarker in individuals with or without the APOE Epsilon 4 Allele. Am. J. Pathol. 192, 564\u2013578 (2022).","journal-title":"Am. J. Pathol."},{"key":"2094_CR52","doi-asserted-by":"publisher","first-page":"8098","DOI":"10.1073\/pnas.90.17.8098","volume":"90","author":"WJ Strittmatter","year":"1993","unstructured":"Strittmatter, W. J. et al. Binding of human apolipoprotein E to synthetic amyloid beta peptide: isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl Acad. Sci. USA 90, 8098\u20138102 (1993).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2094_CR53","doi-asserted-by":"publisher","first-page":"9039","DOI":"10.1074\/jbc.270.16.9039","volume":"270","author":"MJ LaDu","year":"1995","unstructured":"LaDu, M. J. et al. Purification of apolipoprotein E attenuates isoform-specific binding to \u03b2-amyloid. J. Biol. Chem. 270, 9039\u20139042 (1995).","journal-title":"J. Biol. Chem."},{"key":"2094_CR54","doi-asserted-by":"publisher","first-page":"23403","DOI":"10.1016\/S0021-9258(17)31529-6","volume":"269","author":"MJ LaDu","year":"1994","unstructured":"LaDu, M. J. et al. Isoform-specific binding of apolipoprotein E to \u03b2-amyloid. J. Biol. Chem. 269, 23403\u201323406 (1994).","journal-title":"J. Biol. Chem."},{"key":"2094_CR55","doi-asserted-by":"publisher","first-page":"5914","DOI":"10.1074\/jbc.M112.442103","volume":"288","author":"LM Tai","year":"2013","unstructured":"Tai, L. M. et al. Levels of soluble apolipoprotein E\/amyloid-\u03b2 (A\u03b2) complex are reduced and oligomeric A\u03b2 increased with APOE4 and Alzheimer disease in a transgenic mouse model and human samples. J. Biol. Chem. 288, 5914\u20135926 (2013).","journal-title":"J. Biol. Chem."},{"key":"2094_CR56","doi-asserted-by":"publisher","first-page":"15181","DOI":"10.1523\/JNEUROSCI.1542-12.2012","volume":"32","author":"T Hashimoto","year":"2012","unstructured":"Hashimoto, T. et al. Apolipoprotein E, especially apolipoprotein E4, increases the oligomerization of amyloid \u03b2 peptide. J. Neurosci. 32, 15181\u201315192 (2012).","journal-title":"J. Neurosci."},{"key":"2094_CR57","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1084\/jem.20171265","volume":"215","author":"JD Ulrich","year":"2018","unstructured":"Ulrich, J. D. et al. ApoE facilitates the microglial response to amyloid plaque pathology. J. Exp. Med. 215, 1047\u20131058 (2018).","journal-title":"J. Exp. Med."},{"key":"2094_CR58","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1038\/s43587-023-00491-1","volume":"3","author":"S-F Lau","year":"2023","unstructured":"Lau, S.-F. et al. The VCAM1\u2013ApoE pathway directs microglial chemotaxis and alleviates Alzheimer\u2019s disease pathology. Nat. Aging 3, 1219\u20131236 (2023).","journal-title":"Nat. Aging"},{"key":"2094_CR59","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1002\/alz.12287","volume":"17","author":"AJ Griswold","year":"2021","unstructured":"Griswold, A. J. et al. Increased APOE \u03b54 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds. Alzheimers Dement. 17, 1179\u20131188 (2021).","journal-title":"Alzheimers Dement."},{"key":"2094_CR60","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.3233\/JAD-221167","volume":"93","author":"LKL Huggins","year":"2023","unstructured":"Huggins, L. K. L. et al. Meta-analysis of variations in association between APOE \u025b4 and Alzheimer\u2019s disease and related dementias across Hispanic regions of origin. J. Alzheimers Dis. 93, 1095\u20131109 (2023).","journal-title":"J. Alzheimers Dis."},{"key":"2094_CR61","doi-asserted-by":"publisher","first-page":"1236","DOI":"10.3390\/jcm8081236","volume":"8","author":"KY Choi","year":"2019","unstructured":"& Choi, K. Y. APOE promoter polymorphism-219T\/G is an effect modifier of the influence of APOE \u03b54 on Alzheimer's disease risk in a multiracial sample. J. Clin. Med. 8, 1236 (2019).","journal-title":"J. Clin. Med."},{"key":"2094_CR62","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1002\/ajpa.21298","volume":"143","author":"DT Eisenberg","year":"2010","unstructured":"Eisenberg, D. T., Kuzawa, C. W. & Hayes, M. G. Worldwide allele frequencies of the human apolipoprotein E gene: climate, local adaptations, and evolutionary history. Am. J. Phys. Anthropol. 143, 100\u2013111 (2010).","journal-title":"Am. J. Phys. Anthropol."},{"key":"2094_CR63","doi-asserted-by":"publisher","first-page":"1733","DOI":"10.1194\/jlr.R076315","volume":"58","author":"LM Tai","year":"2017","unstructured":"Tai, L. M. et al. EFAD transgenic mice as a human APOE relevant preclinical model of Alzheimer\u2019s disease. J. Lipid Res. 58, 1733\u20131755 (2017).","journal-title":"J. Lipid Res."},{"key":"2094_CR64","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2019.134285","volume":"707","author":"D Balu","year":"2019","unstructured":"Balu, D. et al. The role of APOE in transgenic mouse models of AD. Neurosci. Lett. 707, 134285 (2019).","journal-title":"Neurosci. Lett."},{"key":"2094_CR65","doi-asserted-by":"publisher","unstructured":"Nemeth, D., Luqman, N., Chen, L. & Quan, N. Aldh1l1-Cre\/ER T2 is expressed in unintended cell types of the salivary gland, pancreas, and spleen. MicroPubl. Biol. https:\/\/doi.org\/10.17912\/micropub.biology.000832 (2023).","DOI":"10.17912\/micropub.biology.000832"},{"key":"2094_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-27293-5","volume":"8","author":"AT McKenzie","year":"2018","unstructured":"McKenzie, A. T. et al. Brain cell type specific gene expression and co-expression network architectures. Sci. Rep. 8, 8868 (2018).","journal-title":"Sci. Rep."},{"key":"2094_CR67","doi-asserted-by":"publisher","first-page":"999","DOI":"10.1016\/j.cell.2018.06.021","volume":"174","author":"A Zeisel","year":"2018","unstructured":"Zeisel, A. et al. Molecular architecture of the mouse nervous system. Cell 174, 999\u20131014 (2018).","journal-title":"Cell"},{"key":"2094_CR68","doi-asserted-by":"publisher","first-page":"1696","DOI":"10.1038\/s41593-019-0491-3","volume":"22","author":"M Ximerakis","year":"2019","unstructured":"Ximerakis, M. et al. Single-cell transcriptomic profiling of the aging mouse brain. Nat. Neurosci. 22, 1696\u20131708 (2019).","journal-title":"Nat. Neurosci."},{"key":"2094_CR69","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1016\/j.cell.2018.02.001","volume":"172","author":"X Han","year":"2018","unstructured":"Han, X. et al. Mapping the mouse cell atlas by Microwell-seq. Cell 172, 1091\u20131107 (2018).","journal-title":"Cell"},{"key":"2094_CR70","doi-asserted-by":"publisher","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","volume":"46","author":"DN Slenter","year":"2018","unstructured":"Slenter, D. N. et al. WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res. 46, D661\u2013D667 (2018).","journal-title":"Nucleic Acids Res."}],"container-title":["Nature Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02094-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02094-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,2]],"date-time":"2025-12-02T23:02:00Z","timestamp":1764716520000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41593-025-02094-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,11]]},"references-count":70,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2094"],"URL":"https:\/\/doi.org\/10.1038\/s41593-025-02094-y","relation":{},"ISSN":["1097-6256","1546-1726"],"issn-type":[{"value":"1097-6256","type":"print"},{"value":"1546-1726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,11]]},"assertion":[{"value":"24 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"D.O.C. is employed by, has equity ownership in and serves on the board of directors of TransViragen, the company which has been contracted by UNC-Chapel Hill to manage its Animal Models Core Facility. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}